Menu

Result Updates

Cipla CEO: Tariff Threat Won't Impact Q4 Growth

Cipla CEO: Tariff Threat Won't Impact Q4 Growth

Cipla CEO: Tariff Threat Won’t Impact Q4 Growth

Cipla, the pharmaceutical giant, revealed that its profit for Q4 FY25 has risen by 30% compared to the previous year. The CEO has addressed concerns about short-term challenges related to U.S. regulatory issues and pricing pressures.

Summary:

Cipla achieved a robust performance in Q4FY25, with revenues increasing by 9% YoY to ₹6,730 crore and a 30% rise in profit after tax, totaling ₹1,222 crore. The company announced an EBITDA of ₹1,538 crore, along with an operating margin of 22.8%. Umang Vohra, the Managing Director and Global CEO of Cipla, mentioned that although U.S. tariffs and potential drug price cuts are looming threats, they are not anticipated to affect the business immediately. Cipla continues to concentrate on expanding its global presence and enhancing its respiratory and peptide portfolios.

Strong Financial Performance in Q4FY25

Cipla Ltd., one of India’s top pharmaceutical companies, posted impressive financial results for the fourth quarter of FY25, reinforcing its resilience in a challenging global pharmaceutical environment. The company’s consolidated revenue rose 9% year-on-year to ₹6,730 crore, driven by potent domestic formulations and continued traction in the U.S. generics and South African markets.
Profit After Tax (PAT) surged 30% YoY to ₹1,222 crore, reflecting operational efficiency, favorable product mix, and cost optimization initiatives. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹1,538 crore, translating into an EBITDA margin of 22.8%, a significant improvement compared to last year.
This performance caps off a year of sustained growth for the Mumbai-based pharma major, which continues to leverage its diversified geographic and therapeutic portfolio.

CEO’s Take on U.S. Tariffs and Pricing Pressure

In the post-earnings call, Umang Vohra, Cipla’s Managing Director and Global CEO, addressed concerns over the U.S. tariff threats and price erosion in the pharmaceutical sector. The U.S. government recently indicated potential tariff revisions and pricing controls for imported drugs to manage rising healthcare costs.
Vohra, however, appeared measured and confident, stating that “we don’t expect an immediate impact from these developments on our U.S. business.” He emphasized that such changes often take time to go through legislative and regulatory cycles. Cipla is well-prepared to navigate them through its broad product pipeline, local partnerships, and operational agility.
He further pointed out that Cipla has been actively working on complex generics, respiratory therapies, and peptide-based drugs, which are less vulnerable to deep pricing pressures due to their differentiated nature.

U.S. Business Remains Key Growth Driver

Cipla’s North American business continues to be a major contributor to revenue, driven by key launches and steady performance in respiratory and peptide segments. In Q4FY25, the U.S. market accounted for nearly 25% of the company’s consolidated revenue, thanks to a consistent supply of respiratory inhalers, limited-competition generics, and traction in institutional sales.
Cipla achieved significant progress during the quarter, especially in the growth of peptide-based injectables and advancements in biosimilars. These segments offer better margins and reduced competition compared to traditional generics, aligning with the company’s long-term strategy to move up the value chain.
Moreover, the company has also invested in front-end capabilities in the U.S. market, ensuring greater control over product distribution and pricing power.

India and South Africa Experience Robust Business Expansion

Cipla’s domestic business grew 11% YoY, underpinned by robust sales in respiratory, urology, and anti-infective therapies. The Indian business remains the most significant revenue contributor, with substantial brand equity and deep reach across urban and rural healthcare networks.
Cipla posted double-digit growth in South Africa with higher sales in over-the-counter (OTC) and prescription medicines. The company’s local manufacturing strategy and tailored product offerings have paid off in the region, especially amid inflationary pressures and currency volatility.
Vohra also mentioned that the South African subsidiary is profitable and exploring partnerships to expand its product portfolio in niche areas.

Research, Innovation, and Global Expansion

Cipla’s R&D expenditure stood at ₹410 crore in Q4FY25, reflecting its commitment to innovation, especially in complex generics, biosimilars, and specialty therapies. The company has over 180 ANDAs (Abbreviated New Drug Applications) filed with the U.S. FDA and several products under development for regulated markets.
Key therapeutic areas under focus include respiratory care, oncology, diabetes, and immunology. Cipla’s management reiterated its ambition to become a global leader in respiratory therapies, supported by cutting-edge inhalation technologies and partnerships.
The company is also looking to deepen its presence in emerging markets of Southeast Asia, Latin America, and the Middle East, where healthcare demand is rising and Cipla’s affordable drug portfolio offers a strategic advantage.

Shareholder Returns and Future Outlook

Cipla is committed to rewarding its shareholders with robust earnings growth and consistent dividends. The company concluded the fiscal year with a strong cash position, low debt levels, and a return on equity (ROE) of 21%, which reflects effective capital utilization.
Looking forward, Cipla’s management is optimistic about FY26 and emphasizes several key points:
– A strong product pipeline in both regulated and semi-regulated markets.
– Increasing need for advanced generics and therapies for long-term health issues.
– Strategic initiatives aimed at cost rationalization to enhance profit margins.
Thanks to its diverse global operations and investments in technology-focused manufacturing platforms, Vohra also pointed out that the company is “well-equipped to handle external challenges,” such as pricing interventions or trade tariffs.

Conclusion

Cipla’s performance in Q4FY25 reflects robust operational strength and strategic durability. The company can sustain growth through product innovation, geographical expansion, and supply chain optimization despite looming macroeconomic headwinds like U.S. drug price reforms and tariff threats.
With a fortified pipeline, increasing focus on differentiated therapies, and prudent risk management, Cipla is set to remain a dominant force in global pharma—balancing affordability with innovation across its core markets.

 

 

 

 

 

 

 

The image added is for representation purposes only

BSE Introduces Investor-Friendly Reforms Amid Growing Market Confidence

 

ITD Cementation Reports Significant Profit Growth in Q4 FY25

ITD Cementation Reports Significant Profit Growth in Q4 FY25

ITD Cementation Reports Significant Profit Growth in Q4 FY25

 

ITD Cementation India Ltd. has reported a notable 27% increase in net profit for the fourth quarter of FY25, highlighting the company’s ongoing operational efficiency and strong market presence. The growth in profit, coupled with an expansion in profit margins, underscores the company’s resilience and ability to adapt to fluctuating market conditions in the infrastructure sector.

Strong Financial Results Amid Challenges

For the quarter ending March 31, FY25, ITD Cementation posted a solid performance with a 27% surge in net profit. This growth is attributed to the company’s strategic approach in diversifying its project portfolio and controlling operational costs. Despite the pressures from rising input costs and uncertainties in the global market, ITD Cementation has continued to thrive by focusing on high-value, long-term contracts.

The infrastructure industry has faced significant challenges due to inflationary trends, supply chain disruptions, and fluctuating raw material prices. However, ITD Cementation’s prudent financial management and strategic execution have allowed it to navigate these challenges successfully. The company’s diversified project base across key infrastructure segments such as urban development, roads, marine, and transportation has been integral in driving consistent performance.

Operational Efficiency and Margin Expansion

A key highlight of ITD Cementation’s Q4 FY25 results is the expansion in operating margins. The company has worked diligently to improve its operational efficiency by leveraging advanced project management technologies and optimizing resource allocation. These efforts have contributed to lower project costs, thereby improving the company’s overall profitability.

The use of digital tools and automation has allowed ITD Cementation to streamline project execution, enhance coordination, and reduce project timelines. These improvements in operational efficiency have provided a competitive edge, enabling the company to maintain strong margins even in the face of rising material and labor costs.

Order Book Growth and Future Prospects

ITD Cementation’s growing order book is another positive indicator of its market standing and future growth prospects. The company has been able to secure several high-profile contracts, including those in critical sectors such as transportation infrastructure and urban development. This diverse mix of projects not only provides a steady revenue stream but also positions ITD Cementation for sustained growth in the coming quarters.

The company’s strong order book ensures that it will continue to generate consistent revenues in the long term, providing a solid foundation for future growth. With major infrastructure initiatives underway both domestically and internationally, ITD Cementation is well-equipped to take advantage of the growing demand for infrastructure development.

Sustainability and Technological Advancements

Alongside its financial success, ITD Cementation remains committed to sustainability and technological innovation. The company has incorporated eco-friendly practices into its project execution, which includes the use of green building materials and energy-efficient construction methods. This focus on sustainability not only aligns with environmental goals but also positions the company to meet the increasing demand for eco-conscious infrastructure projects.

In terms of technological innovation, ITD Cementation has invested in cutting-edge tools to enhance its project management capabilities. By adopting artificial intelligence (AI) and machine learning technologies, the company has been able to improve decision-making, optimize resource utilization, and reduce inefficiencies across its projects. These technological advancements ensure that ITD Cementation remains at the forefront of industry trends and continues to improve its operational performance.

Expanding Market Reach

As ITD Cementation looks ahead, the company is focused on expanding its footprint both within India and internationally. The growing demand for modern infrastructure in emerging markets presents a significant growth opportunity for the company. ITD Cementation’s expertise in handling complex, large-scale projects positions it as a key player in these markets, where infrastructure development is a priority.

Additionally, the company is actively pursuing opportunities in international markets, particularly in regions such as the Middle East and Southeast Asia, where there is a growing demand for infrastructure development. By leveraging its experience and expertise in executing high-value projects, ITD Cementation aims to increase its international presence and diversify its revenue streams.

Looking Ahead: Continued Growth and Success

Overall, ITD Cementation’s Q4 FY25 performance reflects a strong track record of growth, driven by operational excellence, strategic expansion, and a focus on sustainability. With its expanding order book, commitment to technological innovation, and plans for international growth, the company is poised for continued success in the coming fiscal year.

The 27% increase in net profit is just one example of how ITD Cementation has successfully navigated a challenging market landscape. The company’s emphasis on efficiency, sustainability, and growth ensures that it will remain a leader in the infrastructure sector in the years to come.

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

GAIL Secures Five U.S. Bids for LNG Project

 

Anil Ambani’s Reliance Power and Reliance Infrastructure Deliver Multibagger Returns in FY25

Reliance Power Sparks a Comeback with Robust Q4, Shares Surge 10%

Reliance Power Sparks a Comeback with Robust Q4, Shares Surge 10%

 

Reliance Power’s shift from losses to Rs 126 crore profit in Q4 FY25 is driven by reduced expenses and significant debt repayment, boosting investor confidence.

Introduction: A Positive Financial Turnaround for Reliance Power

A noteworthy transformation characterized Reliance Power’s financial results for the final quarter of fiscal year 2025, as the corporation declared a unified net income of Rs 1.26 billion. This stands in stark contrast to the loss of Rs 397.56 crore recorded in the same period the previous year. The surge in profit can be largely attributed to a reduction in expenses, which enabled the company to bounce back in a challenging market environment.

A Look at Q4 FY25 Financials: Profit Despite Declining Income

During the January-March 2025 window, Reliance Power’s overall revenue witnessed a decline, ultimately totaling Rs 20.66 billion, a figure indicative of a decrease. from the Rs 21.9385 billion recorded during the equivalent three-month period of the preceding fiscal cycle. Despite this drop, the company’s sharp reduction in expenses—falling from Rs 2,615.15 crore to Rs 1,998.49 crore—was a critical factor in its ability to report a profitable quarter. This significant shift in performance underscores the corporation’s emphasis on prudent expenditure control and optimized operational processes.

Full-Year Financial Performance: From Loss to Profit

Throughout the entirety of fiscal year 2025, Reliance Power demonstrated remarkable financial improvement, declaring a unified net income of Rs 29.4783 billion, a stark contrast to the substantial net deficit of Rs 20.6838 billion recorded in fiscal year 2024. This achievement underscores the company’s resilience and effective strategic adjustments over the year, despite the challenging economic landscape.

Debt Servicing and Financial Health: A Key Improvement

Beyond its financial gains, Reliance Power also indicated the successful management of its debt obligations, having serviced Rs 53.38 billion in liabilities throughout the preceding year. This included maturity repayments and ongoing debt obligations. Consequently, the corporation’s proportion of liabilities relative to its equity capital saw a positive adjustment, reaching a more sustainable level of 0.88 to 1 in fiscal year 2025, a reduction from the 1.61 to 1 ratio observed in the prior fiscal year. This is a crucial development for the company, as it strengthens its balance sheet and positions it for future growth and stability.

Stock Market Reaction: Reliance Power Shares Surge

Reliance Power’s positive financial performance had an immediate impact on its stock, with shares surging by 10.2% to Rs 42.60 during early trading on the Bombay Stock Exchange (BSE). This increase in share price is a clear reflection of investor confidence, driven by the company’s shift from losses to profitability in Q4 FY25. On the previous Friday, the stock had closed 0.9% higher at Rs 38.6, even as broader market indices like the Sensex fell by 1.1%. Across the preceding biennium, Reliance Power’s equity value has appreciated by a remarkable 222%; however, it has experienced a 13.5% decline in the current year of 2025 to date.

Technical Indicators: A Mixed Signal

Despite the strong gains in the stock price, technical indicators show a more cautious outlook. The Reliance Power stock’s Relative Strength Index (RSI) currently registers at 44.1, suggesting a neutral positioning where it is neither excessively purchased nor excessively sold. The Moving Average Convergence Divergence (MACD) figure of 0.4, which is below both its Signal Line and Center Line, signals a bearish trend. Additionally, the stock is trading below its 10-day, 20-day, 30-day, 100-day, and 150-day simple moving averages (SMA), though it remains above the 50-day and 200-day SMAs, suggesting a mixed technical outlook.

Business Fundamentals: Power Generation and Operational Excellence

Reliance Power, a part of the prominent Reliance Group, has a well-established presence in India’s power generation sector. The company has a substantial operational portfolio of 5,305 megawatts, with 3,960 megawatts coming from its flagship Sasan Power plant. Sasan Power holds the distinction of being the globe’s most extensive fully integrated thermal power generation facility utilizing coal and has consistently achieved the top operational ranking among India’s power plants for the preceding seven years. This operational strength is key to Reliance Power’s long-term growth prospects and its ability to maintain profitability amid fluctuations in the energy market.

Conclusion: Positive Outlook Amid Financial Progress

The robust fiscal outcomes demonstrated by Reliance Power in FY25, characterized by a notable shift to profitability and substantial deleveraging, suggests an optimistic outlook for the organization’s trajectory. While technical indicators suggest some caution in the short term, the company’s operational strength and focus on improving its financial health make it well-positioned to continue benefiting from the growing energy demands in India. With a solid track record and a positive market response to its latest results, Reliance Power’s investors can look forward to a more stable and profitable outlook in the coming quarters.

Final Thoughts

Reliance Power has exhibited noteworthy recovery, transitioning from significant financial deficits to a profit-generating final quarter in the fiscal year 2025. This positive momentum, driven by reduced costs, improved debt management, and strong operational capabilities, has boosted investor confidence, reflected in the stock’s recent surge. With a more favorable debt-to-equity ratio and ongoing profitability, the company is poised for continued success in the energy sector.

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

India Boosts Monetary Policy with Improved Repo Rate Response

 

Britannia Butters Up Bottom Line: Q4 Profit Rises 5% to ₹557 Cr

Britannia Butters Up Bottom Line: Q4 Profit Rises 5% to ₹557 Cr

Britannia Butters Up Bottom Line: Q4 Profit Rises 5% to ₹557 Cr

 

Britannia Industries reported a net profit of ₹557 crore for Q4 FY25, up 5% from last year. Annual revenue hit ₹16,859.2 crore, reflecting a 5.8% increase driven by strong demand and cost optimization.

Summary:

Britannia Industries announced a 5% increase in its consolidated net profit, which amounted to ₹557 crore for the fourth quarter of FY25. The company’s annual revenue grew by 5.8%, totalling ₹16,859.2 crore, and its net profit for the fiscal year increased to ₹2,130.2 crore. This performance highlights effective cost management and steady results in core categories despite inflationary challenges and difficulties in rural demand.

Britannia Shows Resilience with Steady Growth in Q4 FY25

Britannia Industries, a leading player in India’s FMCG sector, has demonstrated its resilience in Q4 FY25 by achieving strong financial results despite challenges such as fluctuating commodity prices, inflation, and a slow recovery in rural markets. For the quarter ending March 31, 2025, the company reported a net profit of ₹557 crore, reflecting a 5% year-on-year growth, which indicates effective operational execution and strategies for protecting margins.

This quarterly performance contributed to an annual revenue of ₹16,859.2 crore for FY25, representing a 5.8% increase from the previous year. The net profit for the year also rose 2.3%, reaching ₹2,130.2 crore, showcasing a stable performance across various product categories.

Financial Highlights: Q4 FY25 and Full-Year Performance

Particulars Q4 FY25 Q4 FY24 % Change (YoY)
Revenue from Operations ₹4,260 crore ₹4,050 crore +5.2%
Net Profit ₹557 crore ₹530 crore +5.0%
EBITDA Margin ~18.8% ~18.3% +50 bps
FY25 Revenue ₹16,859.2 crore ₹15,927.6 crore +5.8%
FY25 Net Profit ₹2,130.2 crore ₹2,082.8 crore +2.3%

Even with global challenges and rising input expenses, the slight increase in profitability highlights Britannia’s strategic focus on cost optimization, value engineering, and operational efficiency. The company’s capacity to sustain gross margins in fluctuating commodity prices, particularly wheat, sugar, and milk, showcases its remarkable resilience.

Management Commentary: Focus on Cost Control and Product Innovation

In a statement regarding the company’s performance, Varun Berry, Vice Chairman & Managing Director of Britannia Industries, remarked: 

“We have consistently performed well this year, maintained our margins and increasing market share across various categories. Our teams have shown agility and efficiency in the face of challenges in the commodity market and a slow recovery in rural demand. We are committed to enhancing our distribution network and developing our brands for the future.”  

The company’s focus on premium products, expansion into the dairy sector, and exploration of opportunities in snacking and health-oriented foods yield positive results. Britannia’s recent products, including milk-based beverages, croissants, and plant-based health snacks, have gained notable popularity, particularly in urban and semi-urban areas.

Rural Demand Remains Soft, Urban Markets Drive Growth

Rural India contributes approximately 30–3 Britannia’s sales and has shown only a slight recovery due to inflationary challenges and inconsistent monsoons. Nevertheless, the company has successfully broadened its rural distribution networks by focusing on low-unit packs (LUPs) and value-for-money options to appeal to budget-conscious consumers. 

In contrast, urban markets emerged as the primary source of growth during the quarter, benefiting significant modern trade and e-commerce channels. The company’s digital commerce division experienced double-digit growth, supported by partnerships with various platforms, including Quick Commerce, which Britannia has actively pursued.

Key Growth Drivers: Innovation, Supply Chain, and Global Expansion

Britannia is progressing in its supply chain by utilizing data-driven insights and updating its warehousing facilities. The company has introduced new manufacturing lines in Uttar Pradesh and Tamil Nadu, enhancing Britannia’s efficiency and lowering logistics expenses. 

On an international scale, Britannia’s operations in Gulf countries, Nepal, Bangladesh, and Africa have helped mitigate some challenges in the domestic market. The company has experienced double-digit growth in its international business, with an increasing export revenue. 

Furthermore, innovations in health and wellness, such as high-fiber biscuits, sugar-free options, and protein-rich cookies, have allowed the company to meet the changing preferences of India’s health-conscious middle class.

Outlook: Optimistic but Cautious

In FY26, Britannia anticipates a stronger recovery in rural markets, bolstered by an expected normal monsoon, increased pre-election spending, and government programs like PM-KISAN and free ration distributions. Commodity prices are projected to stabilize, which may help alleviate some margin pressures.

Nevertheless, the company remains vigilant regarding global inflation trends, fluctuating interest rates, and currency volatility, particularly with its expansion into international markets.

Britannia’s plans include:

– Diversifying its product offerings in snacking and dairy

– Bolster direct sales presence across Tier-2 and Tier-3 locations

– Increasing investments in digital and automation initiatives

– Refining its strategies to align with ESG principles

Conclusion: Steady Execution Amid Economic Challenges

Britannia Industries’ Q4 and FY25 results demonstrate a strategic approach that balances growth with cost management’s consistent performance in the face of macroeconomic challenges. Alongside its investments in innovation and supply chain efficiency, Britannia Industries solidified its status as a robust FMCG leader in India. 

With changing consumption patterns and a resurgence in rural markets, Britannia’s varied product offerings, strong brand reputation, and effective distribution strategies are expected to support a stable growth path in the upcoming fiscal year.

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Adani Wind Sets Ambitious 2.5 GW Target, Eyes Global Expansion

Kalyan Jewellers’ Q1 Revenue Shines, but Share Price Dips

Golden Quarter: Kalyan Jewellers Shines with 36% Profit Jump, ₹1.5 Dividend Sparkle

Golden Quarter: Kalyan Jewellers Shines with 36% Profit Jump, ₹1.5 Dividend Sparkle

 

A Strong Quarter for India’s Leading Jewellery Brand

Kalyan Jewellers, one of India’s most recognized names in the jewellery industry, announced its financial results for the fourth quarter of FY25, showcasing stellar growth in both revenue and net profit. The company delivered a consolidated net profit of ₹187.6 crore, marking a robust 36% year-on-year (YoY) increase from ₹137.5 crore in the same period last year.
The company also reported a sharp rise in operational revenue, which surged by 37% to ₹6,181.5 crore, up from ₹4,534.9 crore in Q4 of FY24. This stellar performance underscores the company’s consistent operational efficiency and strong consumer demand despite ongoing volatility in gold prices and geopolitical uncertainties.

Revenue Drivers: India and Middle East Markets

The domestic business of Kalyan Jewellers was crucial in propelling expansion. Revenue from its India operations stood at ₹5,350 crore in Q4 FY25, up 38% YoY, reflecting continued strong demand for gold and diamond jewellery across the country.
The Middle East segment, which contributes a significant portion of international sales, also posted healthy growth. Revenue from this market rose to ₹784 crore, representing a 26% YoY increase. This performance is commendable given the macroeconomic headwinds and foreign exchange fluctuations in the region.
The company’s expansion strategy—especially the addition of new showrooms in both India and the Middle East—has positively impacted revenue growth across key geographies.

E-Commerce Arm Candere Posts Mixed Results

While the core jewellery business shone brightly, Kalyan’s online jewellery brand Candere had a more subdued quarter. It reported revenue of ₹28 crore, but also a net loss of ₹12 crore for Q4 FY25. The company cited ongoing investments in technology, logistics, and customer acquisition as reasons for the losses.
Candere continues to be a long-term bet for Kalyan Jewellers, especially with younger demographics increasingly shopping online. However, sustained losses suggest that the e-commerce unit will need more time to become a meaningful contributor to the bottom line.

Final Dividend Announced

The Board has recommended a final dividend of ₹1.5 per equity share for FY25, subject to shareholder approval. This action demonstrates Kalyan Jewellers’ continued dedication to providing investors with consistent returns. The choice demonstrates the company’s methodical financial approach, which strikes a balance between strong expansion plans and an emphasis on compensating stakeholders.

Executive Commentary

Commenting on the results, Ramesh Kalyanaraman, Executive Director of Kalyan Jewellers, expressed satisfaction with the performance:
“We have concluded an excellent financial year and entered FY26 on a strong note. Despite continued volatility in gold prices, we have seen encouraging traction from consumers, particularly during the wedding season and recent Akshaya Tritiya celebrations.”
He added that the company’s expansion strategy and customer-centric approach remain the cornerstone of its success. Kalyanaraman also emphasized the growing acceptance of their digital platforms and omni-channel presence, which played a crucial role in attracting new customers.

Financial Year Summary and Outlook

Kalyan Jewellers has reported strong success in FY25. The company’s full-year revenue and profit both registered double-digit growth, reflecting operational resilience in a competitive and price-sensitive market.
Kalyan intends to keep up its aggressive expansion approach in the future. It is targeting underpenetrated Tier II and Tier III cities in India, as well as newer locations in the Gulf region. The company aims to leverage its brand trust, affordability focus, and customer service to deepen market penetration.
Industry analysts believe that the Indian jewellery sector will continue to grow steadily due to rising disposable income, cultural factors, and increased formalization. Kalyan Jewellers, with its strong brand recall and broad presence, is well-positioned to capitalize on this trend.

Challenges Ahead

Despite the strong quarter, Kalyan Jewellers faces several external challenges. Gold price volatility, changing consumer preferences, regulatory shifts, and international currency fluctuations could impact future earnings. Moreover, competition from local jewellers and other organized players like Tanishq and Malabar Gold remains intense.
Still, with strong management, a growing store network, and increasing digital integration, the company appears well-equipped to navigate future uncertainties.

Conclusion

Kalyan Jewellers’ Q4 FY25 results are a testament to the company’s robust business model, customer loyalty, and operational excellence. With a 36% jump in profit, a 37% revenue boost, and a final dividend of ₹1.5, the jewellery major continues to shine bright in India’s retail landscape. As the company enters the next fiscal year with aggressive expansion and a digital-first approach, it is poised to further solidify its market leadership.

 

 

 

 

 

The image added is for representation purposes only

The Parag Parikh Fund has more over ₹1 lakh billion in assets under management.

Alembic Pharma Q4 FY25: Profit Slips 12% Despite Strong Revenue Growth

Alembic Pharma Q4 FY25: Profit Slips 12% Despite Strong Revenue Growth

Alembic Pharma Q4 FY25: Profit Slips 12% Despite Strong Revenue Growth

 

Alembic Pharmaceuticals Ltd., one of India’s established pharmaceutical companies, announced its financial results for the fourth quarter of the fiscal year 2024–25 (Q4 FY25), showcasing a mixed performance. While the company achieved robust revenue growth of 17% year-on-year (YoY), its net profit slipped 12%, reflecting the challenges of operating in a highly competitive and regulated global pharmaceutical landscape.
In Q4 FY25, Alembic Pharma reported consolidated revenues of ₹1,770 crore, a significant increase from ₹1,513 crore in the same quarter of the previous year. This growth was primarily driven by a strong performance in the US generics segment and stable growth in the domestic branded formulations business. However, the quarter’s net profit dropped to ₹155 crore from ₹176 crore in Q4 FY24, indicating pressure on operating expenses and margins.
Revenue Drivers and Segment Performance

Domestic Branded Business

In Q4 FY25, Alembic’s India division, which accounts for a significant portion of its total sales, reported a 3% YoY gain, bringing in ₹614 crore. The growth was attributed to increased traction in specialty therapies, including gynecology, cardiology, anti-diabetics, and ophthalmology segments. Alembic has been investing in strengthening its field force and expanding its presence in tier 2 and tier 3 markets, which is gradually reflecting in its numbers.
The company’s consistent focus on specialty therapeutic areas is seen as a positive shift from the generic-heavy approach, helping build long-term brand value and prescription stickiness among healthcare providers.

US Generics Business

Revenue for the US generics business reached ₹521 crore during the quarter, indicating a robust 10% YoY rise. The US continues to be a strategic market for Alembic, supported by the timely launch of new products and a focus on niche complex generics. During Q4, the company launched two products in the US, and with over 20 launches planned for FY25, Alembic expects this momentum to continue.
The company’s recently commercialized manufacturing facilities in Jarod and Karkhadi are expected to play a crucial role in supporting future growth in the US by expanding capacity and regulatory compliance.

Ex-US International Generics

Outside the US, the company’s international generics business—serving regions such as Europe, Canada, Australia, and emerging markets—recorded a 10% YoY growth with revenue of ₹299 crore. Growth in this segment was led by increased demand for select products and the gradual expansion of product offerings across therapeutic categories.

Active Pharmaceutical Ingredients (API) Business

Q4 saw a decline in Alembic’s API business, in contrast to its formulation segments. The API segment generated ₹259 crore in revenue, registering a 10% YoY decline. The dip was attributed to softening global demand, increased competition, and pricing pressures in certain key molecules. Due to destocking efforts, several of Alembic’s API clients in regulated markets also decreased their purchases.
Despite the short-term decline, management remains optimistic about the API business, especially with long-term backward integration plans and differentiated API development.

Profitability and Margins

While revenue growth was solid, profitability faced headwinds. EBITDA for the quarter stood at ₹269 crore, and the EBITDA margin came in at 15.2%, down from 17.5% in the year-ago period. The fall in profit and margin was largely driven by elevated operational expenses, pricing pressure in select international markets, and an increase in R&D spend.
Approximately 8.8% of total sales, or ₹156 crore, was spent on research and development during the quarter. This investment is part of Alembic’s long-term strategy to enhance its complex generics pipeline, particularly in the US market. The company currently has over 180 ANDAs filed with the US FDA, with 126 approvals already received.
Management Commentary and Strategic Direction
Commenting on the results, Mr. Shaunak Amin, Managing Director of Alembic

Pharmaceuticals, stated:

“India’s branded business continues to improve its execution capabilities in both quality and scale. The animal health and specialty markets grew rapidly. The US business outlook appears optimistic, with the commercialization of new facilities and a healthy pipeline of upcoming launches. We are committed to improving cost structures and enhancing profitability going forward.”
Alembic aims to improve its EBITDA margin in the coming quarters by focusing on operational efficiencies, rationalizing R&D expenses, and leveraging scale across its manufacturing platforms. With the US pipeline maturing and global demand for complex generics rising, the company is well-positioned for steady growth over the next two to three years.

Outlook for FY26

In the future, Alembic is still committed to growing its holdings in regulated markets and taking advantage of new product introductions in the US. Its strong ANDA pipeline, expanding international footprint, and capacity additions through new facilities offer visibility for medium-term growth. However, inflationary cost pressures and regulatory hurdles in overseas markets will need careful management.

Conclusion

Alembic Pharma’s Q4 FY25 performance reflects a transitionary phase—while top-line growth is strong, profitability pressures persist. The company’s continued investments in specialty formulations and complex generics, coupled with a long-term vision, are likely to bear fruit as the macroeconomic environment stabilizes and regulatory approvals increase. For investors and stakeholders, the story ahead hinges on execution, especially in high-margin markets like the US.

 

 

 

 

 

 

The image added is for representation purposes only

Profit Surge Heats Up Blue Star’s Q4: ₹9 Dividend to Cool Investors

Profit Surge Heats Up Blue Star’s Q4: ₹9 Dividend to Cool Investors

Profit Surge Heats Up Blue Star’s Q4: ₹9 Dividend to Cool Investors

Profit Surge Heats Up Blue Star’s Q4: ₹9 Dividend to Cool Investors

Fueled by strong summer demand and a healthy order book, Blue Star announced a more than 20% year-on-year increase in revenue and profit for Q4 FY25. The impressive growth in room air conditioners and project businesses helps maintain momentum into FY26.

Summary:

Blue Star Ltd announced a consolidated net profit of ₹194 crore for Q4 FY25, reflecting a year-on-year increase of 21.5%. This growth was driven by strong demand during the summer months and strategic inventory management by distributors. Revenue from operations grew by 20.8% compared to the previous year, totaling ₹4,018.96 crore. For the entire fiscal year, the company’s net profit surged by 42.7% to ₹591 crore, alongside a revenue achievement of ₹11,976 crore. Blue Star’s board proposed a final dividend of ₹9 per share, underscoring the company’s robust financial position.

Q4 FY25 Results: Robust Growth Driven by Room AC Demand and Project Execution

Blue Star Limited’s performance in the fourth quarter of FY25 showcased robust operational execution and continued consumer interest, especially in its Unitary Products and Electro-Mechanical Projects segments. The company posted consolidated revenue of ₹4,018.96 crore for Q4 FY25, reflecting a 20.8% increase compared to ₹3,327.77 crore in Q4 FY24. The net profit, excluding exceptional items, surged by 21.5% to ₹194 crore, up from ₹159.71 crore in the same quarter the previous year.
Operating profit (PBIDTA excluding other income) rose 15.5% year-on-year to ₹279.40 crore, although the margin slightly declined from 7.3% to 7.0%. This drop was mainly due to increased promotional expenditures in the room air conditioning sector and rising input costs. Nevertheless, the overall operating leverage remained healthy.
Before accounting for exceptional items, the Profit Before Tax increased by 16.2% YoY, reaching ₹248.82 crore. At the same time, other income nearly doubled to ₹23.99 crore, indicating enhanced treasury performance driven by a larger cash surplus.

Full-Year FY25 Performance: Revenue Crosses ₹12,000 Crore Milestone

Blue Star reported a consolidated revenue of ₹11,976.65 crore for FY25, marking a 23.6% year-on-year increase from ₹9,685.36 crore in FY24, highlighting robust growth across its main sectors. The company’s net profit surged by 42.7% year-on-year to ₹591.28 crore, supported by operational efficiencies and a gain of ₹10.37 crore from exceptional items.
Operating profit for FY25 reached ₹875.92 crore, reflecting a 31.8% year-on-year increase and boosting the operating margin to 7.3%. The Earnings Per Share (EPS) grew to ₹28.76, up from ₹20.77 in the previous year.
Finance costs declined 16% year-on-year to ₹48.80 crore due to reduced borrowings and effective working capital management.The company closed the fiscal year with a strong net cash position of ₹640 crore.

Segment Performance: Room AC Business Shines Bright

-Unitary Products Segment: Revenue grew by 22.4% to ₹5,621 crore, with segment profits rising by 30.8% to ₹471.26 crore. The growth was driven by robust channel stocking ahead of summer and the introduction of new premium air conditioning products.
-Electro-Mechanical Projects & Commercial Air Conditioning: Revenue increased by 27.2% to ₹5,998 crore, while profits soared by 43.9% to ₹490.88 crore. This growth was fueled by strong demand from data centers, manufacturing, healthcare, and hospitality sectors. However, commercial real estate and banking, financial services, and insurance (BFSI) segments showed slow performance.
-Professional Electronics & Industrial Systems: This segment encountered challenges, with revenue falling by 7.7% to ₹348.55 crore and profits declining by 42.3% to ₹29.72 crore, mainly due to weak demand in the Data Security and Med-Tech sectors.

Dividend and Shareholder Updates

The board has announced a final dividend of ₹9 per share for FY25, which marks an increase from the ₹7 dividend declared the previous year. The company’s 77th Annual General Meeting (AGM) is on August 6, 2025. The record date to be eligible for the dividend is July 18, 2025, with book closure from July 19 to August 6.

Brokerages Maintain Positive Outlook

Brokerages are optimistic about Blue Star’s prospects. The company boasts a solid order book of ₹6,263 crore, representing a 9.9% increase year-on-year. Analysts expect ongoing earnings growth due to the rising demand for cooling solutions influenced by climate change. Blue Star’s strategic emphasis on innovation, a robust supply chain, and customer-focused solutions is vital for sustainable growth.
Nuvama continues to endorse a “buy” rating for the stock and has updated its target price to ₹1,550. They highlight strong earnings visibility, a trend towards premium products in consumer appliances, and a rise in capital expenditure from government and private sectors in infrastructure as significant contributors.

Future Outlook: Optimism Tempered by Market Volatility

Chairman and Managing Director Vir S. Advani stated, “We’re proud to achieve our third consecutive year of remarkable performance. Although April 2025 started slowly due to milder temperatures, we anticipate strong demand in May and June. The challenges in Commercial Refrigeration are now behind us. With our updated product range and the growth of market segments such as data centers and healthcare,” we are confident in our outlook.”
He also emphasized that the company closely monitors geopolitical risks, fluctuations in global commodity prices, and supply chain issues. Despite these challenges, the company is dedicated to enhancing its manufacturing capabilities and maintaining Star’s leadership position in the Indian Market.

Conclusion

Blue Star’s fourth quarter and full year 2025 results highlight the company’s strong business fundamentals, it’s capacity to adapt to economic fluctuations and its enhanced commitment to innovation and operational excellence. With impressive growth across various segments, a growing product portfolio, and a management set, Blue Star is strategically positioned for ongoing growth in fiscal year 2026. The proposed ₹9 dividend demonstrates management’s confidence in creating shareholder value.

 

 

 

 

 

The image added is for representation purposes only

 Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

Voltas Q4 FY25: Profit More Than Doubles to ₹241 Crore, Dividend Declared

Voltas Q4 FY25: Profit More Than Doubles to ₹241 Crore, Dividend Declared

Voltas Q4 FY25: Profit More Than Doubles to ₹241 Crore, Dividend Declared

 

Voltas Ltd., a leading provider of air conditioning and engineering solutions, part of the prestigious Tata Group, has posted outstanding financial results for the fourth quarter (Q4) of fiscal year 2025 (FY25). The company has reported a net profit of ₹241 crore, which is more than double the ₹116 crore earned in the same quarter last year. This noteworthy 108% year-over-year (YoY) increase illustrates Voltas’ tenacity and fortitude, even in the face of the uncertain 2025 economic environment.
Alongside this impressive profit surge, Voltas has also announced a dividend of ₹7 per share for its shareholders, underlining its commitment to delivering value to investors. The board’s decision to recommend a substantial dividend shows the company’s solid financial health and operational efficiency.

Key Financial Highlights for Q4 FY25

• Revenue Growth: Voltas has registered a 13.42% increase in revenue, rising from ₹4,203 crore in Q4 FY24 to ₹4,767 crore in Q4 FY25. This increase underscores the company’s robust market performance and its ability to generate consistent revenues across its business segments.
• EBITDA Surge: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased by 74.6% to ₹332.8 crore for the firm, up from ₹191 crore for the same period last year. This remarkable increase in operational profit demonstrates how well Voltas’ operations run and how it can control expenses while boosting its capacity to generate income.
• Operating Margin: Voltas also saw a significant improvement in its operating margin, which increased to 7% from 4.5% in Q4 FY24. This increase highlights the company’s ability to manage its costs while improving profitability, even as the market conditions have been challenging.

Segment Performance: Driving Growth

Voltas operates in two major segments: Unitary Cooling Products (UCP) and Electro-Mechanical Projects and Services (EMPS). Both segments have contributed significantly to the company’s growth in Q4 FY25, showcasing the diversity and stability of Voltas’ revenue streams.
• Unitary Cooling Products (UCP): The UCP segment, which includes Voltas’ air conditioning and refrigeration solutions, has continued to perform well in the market. In Q4 of FY25, this segment’s revenue jumped to ₹892 crore, a significant rise over the ₹693 crore it generated in the same period the previous year. This growth can be attributed to the rising demand for cooling solutions, especially during the peak summer months, and Voltas’ strong brand presence in the Indian market. The company’s innovative offerings and emphasis on energy-efficient solutions have helped it gain a competitive edge in this fast-growing segment.
• Electro-Mechanical Projects and Services (EMPS): The EMPS segment, which deals with large-scale infrastructure projects, also posted strong results, with revenue rising by 13% to ₹4,157 crore for FY25, compared to ₹3,683 crore in FY24. This segment’s growth reflects the increasing demand for infrastructure solutions, especially in the fields of HVAC (Heating, Ventilation, and Air Conditioning), refrigeration, and other engineering services for large commercial and industrial projects. Voltas’ ability to execute complex projects efficiently has allowed it to capitalize on the growing infrastructure boom in India and other regions.

Dividend Declaration: A Shareholder-Friendly Move

Reaffirming its dedication to long-term shareholder value, the Voltas board has recommended a dividend of ₹7 per equity share for FY25. The dividend announcement comes as a reflection of the company’s strong cash flow and profitable operations, enabling it to reward shareholders. This dividend recommendation aligns with Voltas’ consistent track record of providing stable returns to its investors, and it will further enhance investor sentiment and confidence in the company’s long-term growth prospects.
The dividend payout is expected to be approved at the company’s annual general meeting (AGM), and Voltas has yet to announce the record date for the dividend. This decision aligns with Voltas’ ongoing strategy of rewarding investors while continuing to reinvest profits into expanding its operations and developing new business avenues.

Market Performance: Investor Confidence in Voltas

Following the announcement of its impressive financial results, Voltas’ stock price saw a positive movement in the market. The company’s shares rose by over 3% on the Bombay Stock Exchange (BSE), reflecting strong investor confidence. This growth in stock price can be attributed to the company’s strong financial performance, the doubling of profits, and the dividend declaration, all of which have positively impacted investor sentiment.
Investors have shown optimism about Voltas’ ability to sustain its growth momentum, particularly in the air conditioning and engineering solutions markets, which are expected to continue expanding in the coming years. The company’s focus on energy-efficient solutions and innovative product offerings has positioned it well to benefit from growing trends in sustainability and green building solutions.

Conclusion: A Promising Outlook

Voltas’s success in Q4 FY25 shows that it can take advantage of market possibilities and adapt to changing market conditions. The company’s more than doubling of profits, coupled with a solid revenue increase, reflects its strong operational execution and effective market strategy. The dividend declaration further reinforces its commitment to shareholder value, making Voltas a solid choice for investors seeking stable returns.
Looking ahead, Voltas is well-positioned to maintain its growth trajectory, driven by strong demand in both the cooling products segment and the infrastructure services sector. The company’s focus on innovation, sustainability, and operational efficiency will continue to play a crucial role in its future success.

 

 

 

The image added is for representation purposes only

Pace 360’s Bold Move: YES Bank Shares Expected to Yield 15-20% Returns

Sonata Software Sees Solid Q4 Revenue Rise, Minor Profit Decline

Sonata Software Sees Solid Q4 Revenue Rise, Minor Profit Decline

Sonata Software Sees Solid Q4 Revenue Rise, Minor Profit Decline

 

The tech services firm announces ₹4.4 per share dividend as it strengthens its position with robust top-line growth and strategic global deals

Introduction

Sonata Software, a prominent player in the digital transformation and IT services sector, has reported a healthy rise in its revenue for the fourth quarter of the financial year 2024–25. Despite a modest drop in net profit, the company’s continued growth in international markets, successful client acquisitions, and strong dividend payout underline a confident and resilient performance.

Revenue Rises Over 19% YoY

During the fourth quarter of fiscal year 2025, Sonata Software generated ₹2,617.2 crore in consolidated revenue, reflecting a growth of over 19% compared to the same quarter in the previous fiscal year. The increase reflects the company’s robust pipeline of enterprise deals and growing demand for its IT and digital transformation services across key geographies.
Much of the company’s revenue boost can be attributed to a surge in its international IT services business, which continues to drive Sonata’s topline. As more global enterprises accelerate their cloud adoption, AI integration, and digital workflows, Sonata has positioned itself as a go-to partner for scalable and efficient solutions.

Net Profit Records Marginal Decline

Sonata Software earned ₹107.5 crore in net profit for Q4 FY25, which is around 3% lower than what it made in the same quarter a year ago, despite solid revenue growth.
This minor dip was due to higher operational costs and increased investment in new strategic initiatives, including talent acquisition and technology upgrades.
However, on a quarter-on-quarter basis, the profit showed a 2% improvement, signaling stability in earnings and the ability to sustain profitability despite competitive industry pressures.

Final Dividend Declared at 440%

Sonata Software announced a final dividend of ₹4.4 per share for FY25, showing its aim to share profits and maintain steady returns for its shareholders.
This payout, which reflects 440% on a face value of ₹1, highlights the company’s continued focus on creating shareholder value even while investing in long-term growth opportunities.
This move comes after a steady track record of dividend declarations by the company and further demonstrates its strong cash position and commitment to distributing profits responsibly.

Share Price Reacts Positively

After the earnings report, Sonata Software’s stock rose by almost 5% in market trading.
The markets responded favorably not just to the revenue growth but also to the company’s execution capabilities, resilient profit margins, and forward-looking dividend declaration.
The uptick in share price also signals investor confidence in the firm’s global expansion strategy and its ability to secure high-value tech transformation contracts.

International Expansion and Strategic Wins

Sonata has made significant inroads in international markets, especially in the US and Europe, with two major client acquisitions during the quarter. These wins reinforce the company’s strengths in delivering complex IT services to enterprise clients looking to modernize operations.
The company’s management emphasized its intent to keep investing in digital capabilities, artificial intelligence, cloud solutions, and customer experience platforms — areas that are critical to its global clients’ business transformation goals.
Sonata also noted a notable improvement in EBITDA margins for its international operations, signaling increased operational efficiency and better resource allocation.

Focus on Technology-Led Growth

With technology at the heart of its strategy, Sonata is committed to deepening its offerings in data-driven digital services. The company continues to focus on building solutions around AI, automation, cloud-native development, and modern enterprise platforms like Microsoft Dynamics and SAP.
Its integrated approach to digital engineering and business IT has helped the firm create value-added services that go beyond traditional outsourcing, offering transformation at scale.

Conclusion

Sonata Software’s fourth-quarter performance for FY25 paints a picture of a company that is growing in both size and strategic focus. While net profit saw a slight year-on-year dip, the significant increase in revenue and solid dividend payout reflect underlying strength.
With momentum from key international deals, increasing EBITDA margins, and a technology-first growth model, Sonata is poised to further strengthen its presence in the global IT services landscape.
Investors, analysts, and stakeholders are likely to view the company’s performance as a mix of prudent financial management and strategic foresight — an encouraging sign for future quarters.

 

 

The image added is for representation purposes only

FIIs Extend 15-Day Bull Run, Markets Steady Despite Operation Sindoor

India’s E-Bus Revolution Gets $137 Million IFC Backing

JBM Auto's EV Growth Produces Excellent FY25 Results

JBM Auto’s EV Growth Produces Excellent FY25 Results

 

JBM Auto Delivers Robust FY25 Results, Declares Dividend, and Accelerates EV Expansion

JBM Auto Limited, a prominent player in India’s automotive and electric mobility space, has reported a strong financial performance for the fourth quarter and the full fiscal year ending March 31, 2025 (FY25). The company’s results reflect solid momentum across its core segments, improved operational efficiencies, and strategic positioning in the fast-growing electric vehicle (EV) industry.

Q4 FY25 Performance: Growth in Revenue and Profitability

For the January–March 2025 quarter, JBM Auto recorded a total net profit of ₹66.34 crore, up 19% year over year from ₹55.75 crore in Q4 FY24. The company’s operational revenue for the same time last year was ₹1,645.70 crore, which represents a 10.75% increase over ₹1,485.95 crore. Higher domestic demand, more orders coming in, and robust traction in its electric mobility category all contributed to this impressive success. The company also reported an EBITDA of ₹213.60 crore, which was 20.56% more than ₹177.18 crore at the same time previous year. The EBITDA margin rose 50 basis points to 12% in the fourth quarter of FY25. The quarter’s profits per share (EPS), which rose to ₹2.81 from ₹2.36 a year earlier, also showed stronger shareholder returns.

FY25 Annual Results: Continued Growth Trajectory

JBM Auto’s net profit for the year was ₹201.91 crore, 12.91% more than the ₹178.83 crore it earned in FY24. In FY21, the company’s total revenue was ₹5,525.91 crore, up more than 9.87% from FY24’s ₹5,029.67 crore. Over the course of the fiscal year, the EPS rose from ₹7.56 to ₹8.54.

Dividend Announcement: Confidence in Financial Stability

The Board of Directors of JBM Auto declared a final dividend of ₹0.85 per share for FY25, subject to approval at the next Annual General Meeting (AGM), reflecting the company’s sound financial standing and dedication to shareholder returns. Despite the capital-intensive nature of the automotive and electric vehicle industries, the company’s confidence in its profits visibility and future cash flow creation is demonstrated by this dividend distribution.

Segment-Wise Performance: OEM and Components Drive Growth

Among the key business segments:
• The OEM division saw revenues rise 18.11% year-on-year to ₹745.80 crore.
• The component division reported a 5.91% increase, bringing in ₹827.34 crore.
• The tool room division recorded a marginal decline of 0.1%, with revenues at ₹73.07 crore.
These figures highlight broad-based growth in manufacturing and supply chain operations, with the OEM segment benefiting from rising demand in the commercial and electric vehicle categories.

EV Segment: Order Wins Fuel Long-Term Prospects

One of the quarter’s major highlights was JBM Auto’s ₹5,500 crore deal for 1,021 electric buses under the PM e-bus Sewa Scheme-2. The company’s position as a major force in India’s EV revolution is cemented by this order. Both governmental transportation projects and private fleet operators have shown a great deal of interest in its electric bus brand, JBM ECO-LIFE.
The company is now ramping up capacity and infrastructure to meet the growing demand, while also investing in charging solutions, telematics platforms, and battery systems to offer a holistic EV ecosystem. These efforts are aimed at reinforcing its leadership in sustainable mobility and enhancing long-term growth prospects.

Future Outlook: Innovation, Expansion, and Export Potential

Looking ahead, JBM Auto is focused on expanding its EV portfolio to include electric light commercial vehicles (e-LCVs) and smart mobility solutions tailored for urban infrastructure. It is also exploring export opportunities in Southeast Asia, the Middle East, and Africa, capitalizing on the global push toward decarbonized transport.
With a strong order book, improved operational efficiencies, and consistent R&D investment, the company is well-positioned to scale new heights. Collaborations with mobility start-ups and technology partners are expected to accelerate innovation, enabling faster go-to-market strategies for next-generation vehicles.

Stock Performance and Analyst Views

Post-results, JBM Auto’s stock experienced moderate movement. Analysts remain bullish on its long-term prospects, citing its strategic EV investments, steady revenue growth, and robust financials. Brokerages like HDFC Securities and ICICI Direct maintain a positive stance on the stock, highlighting its potential to deliver value amid industry transformation.

Conclusion: Strong Fundamentals with Future-Ready Focus

In India’s fast-paced automotive industry, JBM Auto’s Q4 and FY25 performance attest to its standing as a high-performing, innovation-driven business. JBM Auto is well-positioned to take the lead in the nation’s shift to environmentally friendly transportation because to its increasing sales, better profit margins, and expanding electric vehicle footprint.

The image added is for representation purposes only

DMart Maintains Solid Growth Amid Margin Pressures and Fierce Retail Rivalry